Colorectal cancer is the common name for colon cancer and rectal cancer. Colorectal cancers are the second most common cancer in Europe, and the third most common type of cancer in Finland after prostate cancer and breast cancer.
Approximately 3800 Finns fall ill with colorectal cancer every year, and the incidence is estimated to grow in the future, mainly due to the ageing of the population. However, the prognosis for colorectal cancer is good: 61% of the people falling ill are alive in five years from the diagnosis, and the survival rates are predicted to improve when screening increases and therapies improve.
Comprehensive expertise in colorectal cancer
At Docrates Cancer Center, people with colorectal cancer receive a comprehensive diagnosis, therapy and follow-up without delay and with expertise based on years of experience. The state-of-the-art imaging equipment in our use and the competence of our clinical staff allow us to customise the treatment in an optimal manner for each patient.
Tuomo Alanko, our Chief Physician, is a highly respected specialist in colorectal cancers, with years of experience in the treatment of patients with colorectal cancer. Alongside other forms of treatment of colorectal cancer, Docrates offers intestinal cancer patients first-class pharmacotherapy, which is started without delay and paying particular attention to its optimal implementation.
At Docrates, every patient has his or her personal doctor and dedicated care team, with whom an individual treatment plan is prepared, listening to the patient. Our comprehensive support services guarantee good preconditions for recovering and maintaining good quality of life despite the cancer.
We are ready to offer our help and world-class care for you whether you suspect or have just been diagnosed cancer.
For more information, please call our international team
tel: +358 10 773 2055 or e-mail international (a) docrates.com
Accurate information on aggressiveness and tumor staging form the basis for prostate cancer treatment
In western countries, prostate cancer is the most common cancer type in men. In its early stages, it is often...Read more
Should low-risk prostate cancer be left to active monitoring?
Active treatment vs. monitoring of localised low-risk prostate cancer has long been a contested topic. According to the results of...Read more
Docrates uses the newest drug therapies for breast cancer
New cancer drugs are being developed all the time, and new uses are being found for drugs already in use....Read more
“The future of cancer treatment” is already a reality in Finland – gene profiling may benefit all cancer patients
- Gene profiling is a new method for examining the characteristics of cancer tumors, which is currently useful in the...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.